Literature DB >> 33505322

Comorbid Bipolar Disorder and Migraine: From Mechanisms to Treatment.

Jinfeng Duan1, Rongmei Yang2, Wenwen Lu3, Lingfei Zhao4, Shaohua Hu1, Chenxia Hu5.   

Abstract

Bipolar disorder (BD) is a severe psychiatric disorder characterized by recurrent episodes of manic/hypomanic or depressive symptoms and euthymic periods, with some patients suffering a gradual deterioration of illness and consequent cognitive deficits during the late stage. Migraine is a disease generally without abnormal medical examinations, neurological examinations or laboratory studies, and the diagnosis is made based on the retrospective demonstration of headache features and groupings of disease-associated symptoms. The epidemiology of comorbid BD and migraine is high and it is obligatory to find effective treatments to improve the prognosis. Recent investigations demonstrated that the close relationship between BD and migraine significantly increased the rapid cycling rates of both BD and migraine in patients. Although the detailed mechanism is complex and largely unclear in comorbid BD and migrain, genetic factors, neurotransmitters, altered signaling pathways, disturbances of inflammatory cytokines, and mitochondrial dysfunction are risk factors of BD and migraine. Particularly these two diseases share some overlapping mechanisms according to previous studies. To this end, we call for further investigations of the potential mechanisms, and more efforts are underway to improve the treatment of people with comorbid BD and migraine. In this review, we provide an overview of the potential mechanisms in patients with BD or migraine and we further discuss the treatment strategies for comorbid BD and migraine and it is obligatory to find effective treatments to improve the prognosis. This work will provide insights for us to know more about the mechanisms of comorbid BD and migraine, provides new therapeutic targets for the treatment and give clinicians some guidance for more appropriate and beneficial treatment.
Copyright © 2021 Duan, Yang, Lu, Zhao, Hu and Hu.

Entities:  

Keywords:  bipolar disorder; genetics; inflammation; mechanism; migraine; mitochondrial dysfunction; neurotransmitter; treatment

Year:  2021        PMID: 33505322      PMCID: PMC7829298          DOI: 10.3389/fpsyt.2020.560138

Source DB:  PubMed          Journal:  Front Psychiatry        ISSN: 1664-0640            Impact factor:   4.157


  105 in total

1.  Oxidative stress in early stage Bipolar Disorder and the association with response to lithium.

Authors:  Rafael T de Sousa; Carlos A Zarate; Marcus V Zanetti; Alana C Costa; Leda L Talib; Wagner F Gattaz; Rodrigo Machado-Vieira
Journal:  J Psychiatr Res       Date:  2013-12-06       Impact factor: 4.791

2.  Leptin, adiponectin, and resistin blood adipokine levels in migraineurs: Systematic reviews and meta-analyses.

Authors:  Milad Abbasi; Ali Noori-Zadeh; Ali Seidkhani-Nahal; Mohammadreza Kaffashian; Salar Bakhtiyari; Sajjad Panahi
Journal:  Cephalalgia       Date:  2019-02-24       Impact factor: 6.292

Review 3.  Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity.

Authors:  V Calabrese; G Scapagnini; A M Giuffrida Stella; T E Bates; J B Clark
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

Review 4.  Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.

Authors:  M Berk; F Kapczinski; A C Andreazza; O M Dean; F Giorlando; M Maes; M Yücel; C S Gama; S Dodd; B Dean; P V S Magalhães; P Amminger; P McGorry; G S Malhi
Journal:  Neurosci Biobehav Rev       Date:  2010-10-08       Impact factor: 8.989

5.  Animal model of mania induced by ouabain: Evidence of oxidative stress in submitochondrial particles of the rat brain.

Authors:  Rafael E Riegel; Samira S Valvassori; Guilherme Elias; Gislaine Z Réus; Amanda V Steckert; Bruna de Souza; Fabrícia Petronilho; Elaine C Gavioli; Felipe Dal-Pizzol; João Quevedo
Journal:  Neurochem Int       Date:  2009-05-15       Impact factor: 3.921

6.  Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.

Authors:  Kathleen R Merikangas; Hagop S Akiskal; Jules Angst; Paul E Greenberg; Robert M A Hirschfeld; Maria Petukhova; Ronald C Kessler
Journal:  Arch Gen Psychiatry       Date:  2007-05

7.  Migraine headache in affectively ill latino adults of mexican american origin is associated with bipolarity.

Authors:  Steven C Dilsaver; Franco Benazzi; Ketil J Oedegaard; Ole B Fasmer; Kareen K Akiskal; Hagop S Akiskal
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 8.  Canadian Headache Society Guideline: acute drug therapy for migraine headache.

Authors:  Irene Worthington; Tamara Pringsheim; Marek J Gawel; Jonathan Gladstone; Paul Cooper; Esma Dilli; Michel Aube; Elizabeth Leroux; Werner J Becker
Journal:  Can J Neurol Sci       Date:  2013-09       Impact factor: 2.104

Review 9.  Sodium channel antagonists for the treatment of migraine.

Authors:  Lorenza Chiossi; Andrea Negro; Matilde Capi; Luana Lionetto; Paolo Martelletti
Journal:  Expert Opin Pharmacother       Date:  2014-06-18       Impact factor: 3.889

Review 10.  Bipolar disorder diagnosis: challenges and future directions.

Authors:  Mary L Phillips; David J Kupfer
Journal:  Lancet       Date:  2013-05-11       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.